RASSF1A gene promoter mthylation in esophagel cancer specimens

Diseases of the Esophagus

Volumn 18, Issue 4, 2005, Pages 253-256

  Yamaguchi, Satoru ^a   Kato, H ^a   Miyazaki, T ^a   Sohda, M ^a   Kimura, H ^a   Ide, M ^a   Asao, T ^a   Kuwano, H ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Esophageal cancer; Methylation specific polymerase chain reaction; RASSF1A; Tumor suppressor gene

Indexed keywords

GENOMIC DNA; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RASSF1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE FREQUENCY; GENE INACTIVATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; TUMOR DIFFERENTIATION; AGE; CANCER INVASION; CANCER STAGING; ESOPHAGUS TUMOR; GENE SILENCING; GENETIC EPIGENESIS; GENETICS; MIDDLE AGED; PATHOLOGY; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

AGE FACTORS; CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; EPIGENESIS, GENETIC; ESOPHAGEAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENE SILENCING; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROMOTER REGIONS (GENETICS); SEX FACTORS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEINS;

EID: 33644814593     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2005.00501.x     Document Type: Article

References (21)

1. Bird A. The essentials of DNA methylation. Cell 1992; 70: 5-8.
2. Jones P A, Laird P W. Cancer epigenetics comes of age. Nat Genet 1999; 21: 163-7.
3. Dammann R, Li C, Yoon J H et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000; 25: 315-9.
4. Dammann R, Yang G, Pfeifer G P. Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res 2001; 61: 3105-9.
5. Agathanggelou A, Honorio S, Macartney D P et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene 2001; 20: 1509-18.
6. Mori T, Yanagisawa A, Kato Y et al. Accumulation of genetic alterations during esophageal carcinogenesis. Hum Mol Genet 1994; 3: 1969-71.
7. Ogasawara S, Maesawa C, Tamura G et al. Frequent microsatellite alterations on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 1995; 55: 891-4.
8. Yoon J H, Dammann R, Pfeifer G P. Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas. Int J Cancer 2001; 94: 212-7.
9. Battagli C, Uzzo R G, Dulaimi E et al. Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients. Cancer Res 2003; 63: 8695-9.
10. Byun D S, Lee M G, Chae K S et al. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Cancer Res 2001; 61: 7034-8.
11. Lee M G, Kim H Y, Byun D S et al. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Cancer Res 2001; 61: 6688-92.
12. Kuroki T, Trapasso F, Yendamuri S et al. Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma. Clin Cancer Res 2003; 9: 1441-5.
13. Yamaguchi S, Shinmura K, Saitoh T et al. A single nucleotide polymorphism at the splice donor site of the human MYH base excision repair genes results in reduced translation efficiency of its transcripts. Genes Cells 2002; 7: 461-74.
14. Herman J G, Graff J R, Myohanen S et al. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-6.
15. Yamaguchi S, Asao T, Nakamura J et al. High frequency of DAP-kinase gene promoter methylation in colorectal cancer specimens and its identification in serum. Cancer Lett 2003; 194: 99-105.
16. Tomizawa Y, Kohno T, Kondo H et al. Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma. Clin Cancer Res 2002; 8: 2362-8.
17. Kim D H, Kim J S, Park J H et al. Relationship of Ras association domain family 1 methylation and K-ras mutation in primary non-small cell lung cancer. Cancer Res 2003; 63: 6206-11.
18. Li J, Zhang Z, Dai Z et al. RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancer. Neoplasia 2003; 5: 362-6.
19. Jahr S, Hentze H, Englisch S et al. DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001; 61: 1659-65.
20. Hu Y C, Sidransky D, Ahrendt S A. Molecular detection approaches for smoking associated tumors. Oncogene 2002; 21: 7289-97.
21. Nakayama H, Hibi K, Takase T et al. Molecular detection of p16 promoter methylation in the serum of recurrent colorectal cancer patients. Int J Cancer 2003; 105: 491-3.